![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Q Jiang, AE Takemori, M Sultana, PS Portoghese, WD Bowen, HI Mosberg and F Porreca
Department of Pharmacology, University of Arizona Health Sciences Center, Tucson.
The present study has investigated the direct opioid delta receptor- mediated antinociception produced by i.c.v. administration of the highly selective delta agonists, [D-Pen2,D-Pen5]enkephalin (DPDPE) and [D-Ala2]deltorphin II, as well as that of the less delta-selective [D- Ser2,Leu5,Thr6]enkephalin (DSLET), by using two novel nonequilibrium opioid antagonists, [D-Ala2,Leu5,Cys6] enkephalin (DALCE) and naltrindole 5'-isothiocyanate (5'-NTII). At times ranging from 8 to 48 hr after a single i.c.v. pretreatment of mice with 5'-NTII, the antinociceptive effects of [D-Ala2] deltorphin II were significantly antagonized. In contrast, 5'-NTII pretreatment at times between 10 min and 24 hr failed to antagonize the antinociceptive effects of DPDPE. Previous studies have shown that pretreatment with i.c.v. DALCE produces a dose- and time-related antagonism of DPDPE, but not morphine, antinociception. However, pretreatment with i.c.v. DALCE failed to antagonize the antinociceptive effects of [D-Ala2]deltorphin II. Similarly, i.c.v. administration of DSLET produced time- and dose- related antinociception which was partially antagonized by either beta- funaltrexamine (beta-FNA) or by ICI 174,864 (N,N-dialyl-Tyr-Aib-Aib-Phe- Leu-OH), suggesting mixed activity at mu and delta receptors. ICI 174,864 produced essentially complete antagonism of DSLET antinociception in beta-FNA-pretreated mice. Pretreatment with 5'-NTII (at -8 to -48 hr), blocked the antinociception produced by DSLET in control or in beta-FNA-pretreated mice. In contrast, pretreatment with DALCE failed to antagonize the antinociception produced by i.c.v. DSLET in either control or in beta-FNA-pretreated mice.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  M. M. Lunzer and P. S. Portoghese Selectivity of {delta}- and {kappa}-Opioid Ligands Depends on the Route of Central Administration in Mice J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 166 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Farias III, K. E. Jackson, D. Yoshishige, and J. L. Caffrey Cardiac enkephalins interrupt vagal bradycardia via delta 2-opioid receptors in sinoatrial node Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1693 - H1701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Broom, J. F. Nitsche, J. E. Pintar, K. C. Rice, J. H. Woods, and J. R. Traynor Comparison of Receptor Mechanisms and Efficacy Requirements for delta -Agonist-Induced Convulsive Activity and Antinociception in Mice J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 723 - 729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Wells, J. L. Bartlett, S. Ananthan, and E. J. Bilsky In Vivo Pharmacological Characterization of SoRI 9409, a Nonpeptidic Opioid {micro}-Agonist/delta -Antagonist That Produces Limited Antinociceptive Tolerance and Attenuates Morphine Physical Dependence J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 597 - 605. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. A. Martin and P. L. Prather Interaction of Co-Expressed {micro}- and {delta}-Opioid Receptors in Transfected Rat Pituitary GH3 Cells Mol. Pharmacol., April 1, 2001; 59(4): 774 - 783. [Abstract] [Full Text]
|
|
|
|
|
|
G. L. Fraser, A. A. Pradhan, P. B. S. Clarke, and C. Wahlestedt Supraspinal Antinociceptive Response to [D-Pen2,5]-Enkephalin (DPDPE) Is Pharmacologically Distinct from That to Other delta -Agonists in the Rat J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 1135 - 1141. [Abstract] [Full Text]
|
|
|
|
|
|
T. J. Martin, S. A. Kim, D. G. Cannon, G. M. Sizemore, D. Bian, F. Porreca, and J. E. Smith Antagonism of delta 2-Opioid Receptors by Naltrindole-5'-isothiocyanate Attenuates Heroin Self-Administration but Not Antinociception in Rats J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 975 - 982. [Abstract] [Full Text]
|
|
|
|
|
|
E. J. Bilsky, X. Qian, V. J. Hruby, and F. Porreca Antinociceptive Activity of [beta -Methyl-2',6'-dimethyltyrosine1]-Substituted Cyclic [D-Pen2,D-Pen5]Enkephalin and [D-Ala2,Asp4]Deltorphin Analogs J. Pharmacol. Exp. Ther., April 1, 2000; 293(1): 151 - 158. [Abstract] [Full Text]
|
|
|
|
|
|
G. L. Fraser, J. Holmgren, P. B. S. Clarke, and C. Wahlestedt Antisense Inhibition of delta -Opioid Receptor Gene Function In Vivo by Peptide Nucleic Acids Mol. Pharmacol., April 1, 2000; 57(4): 725 - 731. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. M. Quock, T. H. Burkey, E. Varga, Y. Hosohata, K. Hosohata, S. M. Cowell, C. A. Slate, F. J. Ehlert, W. R. Roeske, and H. I. Yamamura The delta -Opioid Receptor: Molecular Pharmacology, Signal Transduction, and the Determination of Drug Efficacy Pharmacol. Rev., September 1, 1999; 51(3): 503 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Hurley, T. S. Grabow, R. J. Tallarida, and D. L. Hammond Interaction Between Medullary and Spinal delta 1 and delta 2 Opioid Receptors in the Production of Antinociception in the Rat J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 993 - 999. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. E. J. Schultz, A. K. Hsu, and G. J. Gross Ischemic Preconditioning in the Intact Rat Heart Is Mediated by {delta}1- But Not µ- or {kappa}-Opioid Receptors Circulation, April 7, 1998; 97(13): 1282 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Thorat and D. L. Hammond Modulation of Nociception by Microinjection of Delta-1 and Delta-2 Opioid Receptor Ligands in the Ventromedial Medulla of the Rat J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1185 - 1192. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Clark, P. J. Emmerson, A. Mansour, H. Akil, J. H. Woods, P. S. Portoghese, A. E. Remmers, and F. Medzihradsky Opioid Efficacy in a C6 Glioma Cell Line Stably Expressing the Delta Opioid Receptor J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 501 - 510. [Abstract] [Full Text]
|
|
|
|
|
|
F. Noble and B. M. Cox The Role of Dopaminergic Systems in Opioid Receptor Desensitization in Nucleus Accumbens and Caudate Putamen of Rat After Chronic Morphine Treatment J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 557 - 565. [Abstract] [Full Text]
|
|
|
|
|
|
S. J. O'Neill, M. A. Collins, H. O. Pettit, R. W. McNutt, and K.-J. Chang Antagonistic Modulation Between the Delta Opioid Agonist BW373U86 and the Mu Opioid Agonist Fentanyl in Mice J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 271 - 277. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Hepburn, P. J. Little, J. Gingras, and C. M. Kuhn J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1350 - 1356. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
